Timothy R. D. J. Radstake
Correspondence to Dr T R D J Radstake
Department of Rheumatology
Nijmegen Center of Infection
Inflammation and Immunity (N4i) and Nijmegen Center for Molecular Life Science (NCMLS)
The Netherlands;
Name/email consistency: high
- Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulation. Wenink, M.H., Santegoets, K.C., Platt, A.M., van den Berg, W.B., van Riel, P.L., Garside, P., Radstake, T.R., McInnes, I.B. Ann. Rheum. Dis. (2012)
- Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. Radstake, T.R., van Bon, L., Broen, J., Wenink, M., Santegoets, K., Deng, Y., Hussaini, A., Simms, R., Cruikshank, W.W., Lafyatis, R. PLoS. ONE (2009)
- Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. Radstake, T.R., Svenson, M., Eijsbouts, A.M., van den Hoogen, F.H., Enevold, C., van Riel, P.L., Bendtzen, K. Ann. Rheum. Dis. (2009)
- The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patients. Radstake, T.R., Vonk, M.C., Dekkers, M., Schijvenaars, M.M., Treppichio, W.L., Lafyatis, R., Riemekasten, G., van den Hoogen, F., Coenen, M.J. Hum. Immunol. (2009)
- Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis. Radstake, T.R., Fransen, J., Toonen, E.J., Coenen, M.J., Eijsbouts, A.E., Donn, R., van den Hoogen, F.H., van Riel, P.L. Ann. Rheum. Dis. (2007)
- The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis. Radstake, T.R., Franke, B., Wenink, M.H., Nabbe, K.C., Coenen, M.J., Welsing, P., Bonvini, E., Koenig, S., van den Berg, W.B., Barrera, P., van Riel, P.L. Arthritis Rheum. (2006)
- Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors. Radstake, T.R., van der Voort, R., ten Brummelhuis, M., de Waal Malefijt, M., Looman, M., Figdor, C.G., van den Berg, W.B., Barrera, P., Adema, G.J. Ann. Rheum. Dis. (2005)
- Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis. Radstake, T.R., van Lieshout, A.W., van Riel, P.L., van den Berg, W.B., Adema, G.J. Ann. Rheum. Dis. (2005)
- Dendritic cells from patients with rheumatoid arthritis lack the interleukin 13 mediated increase of Fc gamma RII expression, which has clear functional consequences. Radstake, T.R., Nabbe, K.C., Wenink, M.H., Roelofs, M.F., Oosterlaar, A., van Lieshout, A.W., Barrera, P., van Lent, P.L., van den Berg, W.B. Ann. Rheum. Dis. (2005)
- Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Radstake, T.R., Sweep, F.C., Welsing, P., Franke, B., Vermeulen, S.H., Geurts-Moespot, A., Calandra, T., Donn, R., van Riel, P.L. Arthritis Rheum. (2005)
- High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcgammaR triggering. Radstake, T.R., van Lent, P.L., Pesman, G.J., Blom, A.B., Sweep, F.G., Rönnelid, J., Adema, G.J., Barrera, P., van den Berg, W.B. Ann. Rheum. Dis. (2004)
- Increased FcgammaRII expression and aberrant tumour necrosis factor alpha production by mature dendritic cells from patients with active rheumatoid arthritis. Radstake, T.R., Blom, A.B., Slöetjes, A.W., van Gorselen, E.O., Pesman, G.J., Engelen, L., Torensma, R., van den Berg, W.B., Figdor, C.G., van Lent, P.L., Adema, G.J., Barrera, P. Ann. Rheum. Dis. (2004)
